Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma

INTRODUCTION: Glioblastoma (GBM) is identified as a lethal malignant tumor derived from the nervous system. Despite the standard clinical strategy including maximum surgical resection, temozolomide (TMZ) chemotherapy, and radiotherapy, the median survival of GBM patients remains <15 months. Accum...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:CNS Neurosci Ther
Glavni autori: Alafate, Wahafu, Li, Xiaodong, Zuo, Jie, Zhang, Hua, Xiang, Jianyang, Wu, Wei, Xie, Wanfu, Bai, Xiaobin, Wang, Maode, Wang, Jia
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7080429/
https://ncbi.nlm.nih.gov/pubmed/32187449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13297
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items